PropertyValue
?:abstract
  • Coronavirus disease (COVID-19) is caused by SARS-CoV-2 virus, which can result in serious respiratory illnesses such as pneumonia leading to respiratory failure It was first reported in Wuhan, Hubei, China, in December 2019 and rapidly spread globally, becoming a pandemic in March 2020 Among comorbidities observed in SARS-CoV-2 positive patients, hypertension (68 3%) and type 2-diabetes (30 1%) are the most frequent conditions Although symptoms are highly heterogeneous (ranging from absence of symptoms to severe acute respiratory failure), patients with metabolic-associated diseases often experience worse COVID-19 outcomes This review investigates the association between metabolic disorders and COVID-19 severity, exploring the molecular mechanisms potentially underlying this relationship and those that are responsible for more severe COVID-19 outcomes In addition, the role of the main biological processes that may connect metabolic alterations to SARS-CoV-2 infection such as hyperglycemia, immune system deregulation, ACE-2 receptor modulation, and inflammatory response is described The impact of metabolic disorders on the prognosis of COVID-19 has major implications in public health especially for countries affected by a high incidence of metabolic diseases
is ?:annotates of
?:creator
?:journal
  • International_Journal_of_Endocrinology_Print
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • Metabolic Perturbations and Severe COVID-19 Disease: Implication of Molecular Pathways
?:type
?:who_covidence_id
  • #975747
?:year
  • 2020

Metadata

Anon_0  
expand all